These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 26385945)
1. Synthesis of 9-Aminoacridine Derivatives as Anti-Alzheimer Agents. Munawar R; Mushtaq N; Arif S; Ahmed A; Akhtar S; Ansari S; Meer S; Saify ZS; Arif M Am J Alzheimers Dis Other Demen; 2016 May; 31(3):263-9. PubMed ID: 26385945 [TBL] [Abstract][Full Text] [Related]
2. Molecular docking, synthesis and biological evaluation of phenacyl derivatives of 9-aminoacridine as anti-Alzheimer's agent. Munawar R; Mushtaq N; Ahmad A; Saeed SMG; Usmani S; Akhtar S; Saify ZS; Arif M; Akram A Pak J Pharm Sci; 2020 Mar; 33(2):659-668. PubMed ID: 32276912 [TBL] [Abstract][Full Text] [Related]
3. Microwave assisted synthesis of novel hybrid tacrine-sulfonamide derivatives and investigation of their antioxidant and anticholinesterase activities. Ulus R; Zengin Kurt B; Gazioğlu I; Kaya M Bioorg Chem; 2017 Feb; 70():245-255. PubMed ID: 28153340 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of heterobivalent tacrine derivatives as potential multi-functional anti-Alzheimer agents. Luo W; Li YP; He Y; Huang SL; Li D; Gu LQ; Huang ZS Eur J Med Chem; 2011 Jun; 46(6):2609-16. PubMed ID: 21497959 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease. Xie SS; Wang XB; Li JY; Yang L; Kong LY Eur J Med Chem; 2013 Jun; 64():540-53. PubMed ID: 23685572 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of imperatorin analogs and their evaluation as acetylcholinesterase and butyrylcholinesterase inhibitors. Granica S; Kiss AK; Jarończyk M; Maurin JK; Mazurek AP; Czarnocki Z Arch Pharm (Weinheim); 2013 Nov; 346(11):775-82. PubMed ID: 24123207 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of new 2-benzoxazolinone derivatives as potential cholinesterase inhibitors for therapy of alzheimer's disease. Szymański P; Janik A; Zurek E; Mikiciuk-Olasik E Pharmazie; 2011 Jun; 66(6):399-403. PubMed ID: 21699076 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives. Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577 [TBL] [Abstract][Full Text] [Related]
9. New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease. Chufarova N; Czarnecka K; Skibiński R; Cuchra M; Majsterek I; Szymański P Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800050. PubMed ID: 29870588 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of derivatives of tetrahydroacridine as acetylcholinesterase inhibitors. Szymański P; Markowicz M; Mikiciuk-Olasik E Bioorg Chem; 2011 Aug; 39(4):138-42. PubMed ID: 21621811 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of cholinesterase-associated aryl acylamidase activity by anticholinesterase agents: focus on drugs potentially effective in Alzheimer's disease. Costagli C; Galli A Biochem Pharmacol; 1998 May; 55(10):1733-7. PubMed ID: 9634011 [TBL] [Abstract][Full Text] [Related]
12. Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro. Ogura H; Kosasa T; Kuriya Y; Yamanishi Y Methods Find Exp Clin Pharmacol; 2000 Oct; 22(8):609-13. PubMed ID: 11256231 [TBL] [Abstract][Full Text] [Related]
14. Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain. Rakonczay Z Acta Biol Hung; 2003; 54(2):183-9. PubMed ID: 14535624 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro evaluation of N-(Bromobut-3-en-2-yl)-7-methoxy-1,2,3,4-tetrahydroacridin-9-amine as a cholinesterase inhibitor with regard to Alzheimer's disease treatment. Korabecny J; Musilek K; Holas O; Nepovimova E; Jun D; Zemek F; Opletalova V; Patocka J; Dohnal V; Nachon F; Hroudova J; Fisar Z; Kuca K Molecules; 2010 Dec; 15(12):8804-12. PubMed ID: 21127466 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and acetylcholinesterase/butyrylcholinesterase inhibition activity of new tacrine-like analogues. Marco JL; de los Ríos C; Carreiras MC; Baños JE; Badía A; Vivas NM Bioorg Med Chem; 2001 Mar; 9(3):727-32. PubMed ID: 11310608 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease. Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831 [TBL] [Abstract][Full Text] [Related]
20. Phthalimide-Derived N-Benzylpyridinium Halides Targeting Cholinesterases: Synthesis and Bioactivity of New Potential Anti-Alzheimer's Disease Agents. Saeedi M; Golipoor M; Mahdavi M; Moradi A; Nadri H; Emami S; Foroumadi A; Shafiee A Arch Pharm (Weinheim); 2016 Apr; 349(4):293-301. PubMed ID: 26898241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]